
SB 450 – New Hampshire
Status: EnactedYear Introduced: 2022
Year Enacted: 2022
Link: https://www.gencourt.state.nh.us/bill_status/legacy/bs2016/bill_status.aspx?lsr=3071&sy=2022&sortoption=billnumber&txtsessionyear=2022&txtbillnumber=sb450
Relative to the prescription drug affordability board. This bill clarifies the definition of manufacturer and pricing unit for purposes of the prescription drug affordability board; expands the ability of alternates to sit on the prescription drug affordability board; changes the executive director position from a classified to unclassified position; clarifies the board’s authority to assess fees; establishes a dedicated fund to support the board; and establishes a criminal penalty for violation of confidentiality requirements.
Key Issues:
PHARMACEUTICALS
Drug Pricing
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found